BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 20839337)

  • 21. Clinical and diagnostic implications of monoclonal B-cell lymphocytosis.
    Rawstron AC; Hillmen P
    Best Pract Res Clin Haematol; 2010 Mar; 23(1):61-9. PubMed ID: 20620971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
    Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
    Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal B-cell lymphocytosis: recommendations from the Dutch Working Group on CLL for daily practice.
    te Raa GD; van Oers MH; Kater AP;
    Neth J Med; 2012 Jun; 70(5):236-41. PubMed ID: 22744928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
    Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
    PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Popp HD; Flach J; Brendel S; Ruppenthal S; Kleiner H; Seifarth W; Schneider S; Schulze TJ; Weiss C; Wenz F; Hofmann WK; Fabarius A
    Leuk Lymphoma; 2019 Mar; 60(3):795-804. PubMed ID: 30376743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?
    Angelillo P; Capasso A; Ghia P; Scarfò L
    Eur J Intern Med; 2018 Dec; 58():2-6. PubMed ID: 30268574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).
    Rawstron AC; Shanafelt T; Lanasa MC; Landgren O; Hanson C; Orfao A; Hillmen P; Ghia P
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S19-23. PubMed ID: 20839333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
    Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis.
    Amato D; Oscier DG; Davis Z; Mould S; Zheng J; Kolomietz E; Wang C
    Am J Clin Pathol; 2007 Aug; 128(2):333-8. PubMed ID: 17638670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
    Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
    Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.
    Dagklis A; Fazi C; Sala C; Cantarelli V; Scielzo C; Massacane R; Toniolo D; Caligaris-Cappio F; Stamatopoulos K; Ghia P
    Blood; 2009 Jul; 114(1):26-32. PubMed ID: 19029437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
    Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
    Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
    Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F
    Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
    Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
    Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal B-cell lymphocytosis; not the same as B-cell chronic lymphocytic leukaemia.
    Svenningsen M; Herborg LL; Hokland P; Ludvigsen M
    Dan Med J; 2017 Dec; 64(12):. PubMed ID: 29206098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal B-lymphocytosis: demographics, nature and subclassification in 414 community patients.
    Mulligan CS; Thomas ME; Mulligan SP
    Leuk Lymphoma; 2011 Dec; 52(12):2293-8. PubMed ID: 21756037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
    De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
    Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MBL versus CLL: how important is the distinction?
    Scarfò L; Fazi C; Ghia P
    Hematol Oncol Clin North Am; 2013 Apr; 27(2):251-65. PubMed ID: 23561472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.